Inventor · disambiguated record
Raymond A. Stokbroekx
Also filed as: LUYCKX MARCEL · STOKBROEKX RAYMOND · STOKBROEKX RAYMOND A · STOKBROEKX RAYMOND ANTOINE
38 granted patents·788 citations·filing 1979–2003
98Inventor score
Top patents by PatentIndex Score
38 records- 0198US4219559AN-Heterocyclyl-4-piperidinaminesJANSSEN PHARMACEUTICA NV·Filed 1979·Granted Aug 26, 1980·71 cites·19 claims
- 0295US4329353A1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereofJANSSEN PHARMACEUTICA NV·Filed 1981·Granted May 11, 1982·58 cites·12 claims
- 0393US5001125AAnti-virally active pyridazinaminesJANSSEN PHARMACEUTICA NV·Filed 1985·Granted Mar 19, 1991·57 cites·28 claims
- 0493US4992433ANovel pyridazinamine derivativesJANSSEN PHARMACEUTICA NV·Filed 1988·Granted Feb 12, 1991·46 cites·20 claims
- 0591US5231184APridazinamine derivativesJANSSEN PHARMACEUTICA NV·Filed 1991·Granted Jul 27, 1993·54 cites·7 claims
- 0688US4619931A[[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazolesJANSSEN PHARMACEUTICA NV·Filed 1984·Granted Oct 28, 1986·31 cites·3 claims
- 0783US5112825AAntirhinoviral heteroamine-substituted pyridazinesJANSSEN PHARMACEUTICA NV·Filed 1990·Granted May 12, 1992·25 cites·16 claims
- 0882US5650411ASubstituted azolone derivativesJANSSEN PHARMACEUTICA NV·Filed 1994·Granted Jul 22, 1997·24 cites·14 claims
- 0982US4689330AAntidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolaminesJANSSEN PHARMACEUTICA NV·Filed 1986·Granted Aug 25, 1987·20 cites·23 claims
- 1081US4369184A1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivativesJANSSEN PHARMACEUTICA NV·Filed 1980·Granted Jan 18, 1983·17 cites·7 claims
- 1180US5985878AAngiogenesis inhibiting pyridazinaminesJANSSEN PHARMACEUTICA NV·Filed 1998·Granted Nov 16, 1999·50 cites·10 claims
- 1280US5728700ASulfonamide compounds of azolones anti-helicobacter agentsJANSSEN PHARMACEUTICA NV·Filed 1995·Granted Mar 17, 1998·41 cites·4 claims
- 1379US5070090AAntipicorpaviral herterocyclic-substituted morpholinyl alkylphenol ethersJANSSEN PHARMACEUTICA NV·Filed 1990·Granted Dec 3, 1991·20 cites·23 claims
- 1478US5100893AAntipicornaviral pyridazinaminesJANSSEN PHARMACEUTICA NV·Filed 1990·Granted Mar 31, 1992·23 cites·15 claims
- 1577US5637592AAcyl derivatives of azolonesJANSSEN PHARMACEUTICA NV·Filed 1995·Granted Jun 10, 1997·42 cites·11 claims
- 1677US5106973APyridzainamine derivativesJANSSEN PHARMACEUTICA NV·Filed 1990·Granted Apr 21, 1992·18 cites·8 claims
- 1775US5639754AUrea and thiourea derivatives of azolonesJANSSEN PHARMACEUTICA NV·Filed 1995·Granted Jun 17, 1997·32 cites·9 claims
- 1874US4861785ABenzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agentsJANSSEN PHARMACEUTICA NV·Filed 1985·Granted Aug 29, 1989·12 cites·18 claims
- 1972US5811426AUrea and thiourea derivatives of azolonesJANSSEN PHARMACEUTICA NV·Filed 1995·Granted Sep 22, 1998·28 cites·10 claims
- 2072US5710156AEster and carbamate derivatives of azolonesJANSSEN PHARMACEUTICA NV·Filed 1995·Granted Jan 20, 1998·17 cites·14 claims
- 2171US5196535AIntermediates for producing antipicornaviral pyridazinaminesJANSSEN PHARMACEUTICA NV·Filed 1991·Granted Mar 23, 1993·14 cites·8 claims
- 2271US4826848AAntidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolaminesJANSSEN PHARMACEUTICA NV·Filed 1988·Granted May 2, 1989·10 cites·20 claims
- 2369US7208503B2Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivativesJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Apr 24, 2007·4 cites·4 claims
- 2469US5571811ASulfonamide derivatives of azolonesJANSSEN PHARMACEUTICA NV·Filed 1995·Granted Nov 5, 1996·23 cites·16 claims
- 2568US4735942A[[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]-methyl]-1H-imidazoles and 1H-1,2,4-triazoles having antimicrobial propertiesJANSSEN PHARMACEUTICA NV·Filed 1986·Granted Apr 5, 1988·8 cites·15 claims
- 2667US5292738AAnti-virally active pyridazinaminesJANSSEN PHARMACEUTICA NV·Filed 1992·Granted Mar 8, 1994·8 cites·8 claims
- 2763US4861879A[[4-[4-Phenyl-1-piperazinyl)phenoxymethyl]-1-3-dioxolan-2-yl]-methyl]-1H-imidazoles and 1H-1,2,4-triazolesJANSSEN PHARMACEUTICA NV·Filed 1988·Granted Aug 29, 1989·6 cites·7 claims
- 2862US6833369B2Angiogenesis inhibiting 5-substituted-1,2,4,-thiadiazolyl derivativesJANSSEN PHARMACEUTICA NV·Filed 2001·Granted Dec 21, 2004·2 cites·18 claims
- 2962US5157035AAnti-virally active pyridazinaminesJANSSEN PHARMACEUTICA NV·Filed 1991·Granted Oct 20, 1992·6 cites·9 claims
- 3059US6602873B2Angiogenesis inhibiting thiadiazolyl pyridazine derivativesJANSSEN PHARAMACEUTICA N V·Filed 2001·Granted Aug 5, 2003·2 cites·10 claims
- 3155US4216217ANovel (1-arylcycloalkylmethyl) isothiocyanatesJANSSEN PHARMACEUTICA NV·Filed 1979·Granted Aug 5, 1980·3 cites·4 claims
- 3254US4749702AAntidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolaminesJANSSEN PHARMACEUTICA NV·Filed 1987·Granted Jun 7, 1988·4 cites·22 claims
- 3351US5010198AIntermediates for the synthesis of benzoxazol- and benzothiazolamine derivatives, useful as anti-anoxic agentsJANSSEN PHARMACEUTICA NV·Filed 1989·Granted Apr 23, 1991·3 cites·23 claims
- 3444US5434168A4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanolJANSSEN PHARMACEUTICA NV·Filed 1992·Granted Jul 18, 1995·4 cites·10 claims
- 3538US5607932AHeterocyclic derivatives of azolonesJANSSEN PHARMACEUTICA NV·Filed 1995·Granted Mar 4, 1997·3 cites·12 claims
- 3637US5530011A4-[(2-benzothiazolyl)methylamino]-α-[(3,4-difluorophenoxy)methyl]-1-piperidineethanolJANSSEN PHARMACEUTICA NV·Filed 1995·Granted Jun 25, 1996·1 cites·4 claims
- 3735US6265407B1Angiogenesis inhibiting thiadiazolyl pyridazine derivativesJANSSEN PHARMACEUTICA NV·Filed 1998·Granted Jul 24, 2001·1 cites·7 claims
- 3831US5675027AIntermediates for making 4- (2-benzothiazolyl)methylamino!-α- (3, 4-difluorophenoxy)methyl!-1-piperidineethanolJANSSEN PHARMACEUTICA NV·Filed 1995·Granted Oct 7, 1997·0 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →